A modified cyclosporine enhances lentivector transduction ex vivo and in vivo by degrading IFITM3
Authors:
- Dara AnnettDADara Annett
- Kate L. MorlingKMKate L. Morling
- Bethan J. CritchleyBCBethan J. Critchley
- Ben GrahamBGBen Graham
- Valeria PingitoreVPValeria Pingitore
- Thomas E. WhittakerTWThomas E. Whittaker
- Nada KurdiNKNada Kurdi
- Justin WarneJWJustin Warne
- Diego León-RicoDLDiego León-Rico
- Nihansu KuruNKNihansu Kuru
- Sara TorosSTSara Toros
- Tasnim NurullahTNTasnim Nurullah
Preprint
Abstract
Intrinsic innate immune barriers have evolved to suppress viral infection and can reduce effective gene delivery in gene therapy. We have developed BG147, a novel cyclosporine A analogue, optimised via structure-guided design to prevent inhibition of HIV cofactor Cyclophilin A and to specifically inhibit interferon-induced transmembrane proteins (IFITM1-3). BG147 enhances VSV-G pseudotyped lentiviral vector transduction ex vivo in hematopoietic stem and progenitor cells (HSPCs) and in in vivo ocular gene therapy of photoreceptor cells in mice. Upon BG147 treatment, IFITM proteins are mislocalised and degraded through lysosomal acidification-dependent pathways. IFITM3 levels functionally return in cells 96 h after BG147 washout. BG147 promises to transform ex vivo and in vivo eye gene therapies by transiently inhibiting intrinsic immune barriers mediated by IFITM proteins to enhance a wide range of protocols. One Sentence Summary: Modified cyclosporine, BG147, enhances lentivector gene therapy transduction, ex vivo in HSPC and in vivo in mouse photoreceptors, by degrading IFITM3.Keywords
Funding Information
- Wellcome Trust (214344)
- Wellcome Trust (220863)
- Wellcome Trust (217112/Z/19/Z)
- Rosetrees Trust (ID2020/100020)
- UCL Biomedical Research Centre (BRC1191/III/101350)
This publication has 59 references indexed in Scilit:
- Three‐Year Safety Results of SAR422459 (EIAV‐ABCA4) Gene Therapy in Patients With ABCA4‐Associated Stargardt Disease: An Open‐Label Dose‐Escalation Phase I/IIa Clinical Trial, Cohorts 1‐5American Journal of Ophthalmology, 2022
- Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis IJournal of Inherited Metabolic Disease, 2017
- Poloxamer synperonic F108 improves cellular transduction with lentiviral vectorsThe Journal of Gene Medicine, 2012
- The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue VirusCell, 2009
- Stable and efficient intraocular gene transfer using pseudotyped EIAV lentiviral vectorsThe Journal of Gene Medicine, 2005
- Five Recombinant Simian Immunodeficiency Virus Pseudotypes Lead to Exclusive Transduction of Retinal Pigmented Epithelium in RatMolecular Therapy, 2002
- X-ray structures and analysis of 11 cyclosporin derivatives complexed with cyclophilin A 1 1Edited by I. A. WilsonJournal of Molecular Biology, 1998
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991
- Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene-transfer: implications for human gene therapyJournal of Virological Methods, 1989
- Isolierung und Strukturermittlung der neuen Cyclosporine E, F, G, H und IHelvetica Chimica Acta, 1982